atorvastatin has been researched along with Blood Poisoning in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 14 (73.68) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, X; Shi, M; Tai, Y; Tian, J; Xu, W; Zhao, C; Zhu, G | 1 |
| Chang, SS; Hsu, TC; Lee, CC; Lee, M; Lee, MG; Porta, L; Tsai, KC; Yo, CH | 1 |
| Chu, Y; Ding, M; Ma, H; Ren, H; Wang, C; Xu, Q; Yao, Q; Zuo, G | 1 |
| McAuley, DF; O'Kane, CM; Perkins, GD | 1 |
| Boobalan, R; Choudhury, S; Kandasamy, K; Mishra, SK; Parida, S; Reddy, N; Singh, TU; Singh, V; Sukumarn, SV; Thangamalai, R | 1 |
| Coldewey, SM; Thiemermann, C | 1 |
| Choudhury, S; Darzi, SA; Dash, JR; Debroy, B; Kannan, K; Mishra, SK; Parida, S; Paul, A; Pule Addison, M; Singh, TU; Singh, V; Thangamalai, R | 1 |
| Addison, MP; Choudhury, S; Darzi, SA; Dash, JR; Kandasamy, K; Kasa, JK; Maruti, BS; Mishra, SK; Parida, S; Singh, TU; Singh, V | 1 |
| Lee, CR; Zeldin, DC | 1 |
| Freir, NM; Jones, M; Kruger, PS; Roberts, MS; Robertson, TA; Venkatesh, B | 1 |
| Falagas, ME; Kopterides, P | 1 |
| Kathirvel, K; Kuntamallappanavar, G; Leo, MD; Mishra, SK; Subramani, J; Uttam Singh, T | 1 |
| Bagshaw, SM; Bellomo, R; Cruz, DN; Gibney, N; Haase, M; Honore, PM; Joannes-Boyau, O; McAlister, FA; Palevsky, PM; Prowle, J; Ronco, C | 1 |
| Harward, ML; Jones, MA; Joyce, CJ; Kostner, KM; Kruger, PS; Roberts, MS; Venkatesh, B | 1 |
| Calisto, KL; Camacho, AC; Carvalheira, JB; Carvalho, Bde M; Guadagnini, D; Mittestainer, FC; Ropelle, ER; Saad, MJ | 1 |
| Ahanger, AA; Choudhury, S; Kandasamy, K; Mishra, SK; More, AS; Parida, S; Prawez, S; Singh, TU | 1 |
| Barnett, AH; Cooke, MW; Gao, F; Hawkey, P; Hong, T; Jones, A; Linhartova, L; Melody, T; Patel, JM; Perkins, GD; Snaith, C; Thickett, DR | 1 |
| Bailey, M; Bellomo, R; Cooper, DJ; Harward, M; Higgins, A; Howe, B; Jones, D; Joyce, C; Kostner, K; Kruger, P; McNeil, J; Nichol, A; Roberts, MS; Syres, G; Venkatesh, B | 1 |
| Kruger, PS | 1 |
1 review(s) available for atorvastatin and Blood Poisoning
| Article | Year |
|---|---|
Statins for sepsis: a critical and updated review.
Topics: Anticholesteremic Agents; Atorvastatin; Bacterial Infections; Heptanoic Acids; Humans; Pyrroles; Sepsis; Simvastatin; Treatment Outcome | 2009 |
3 trial(s) available for atorvastatin and Blood Poisoning
| Article | Year |
|---|---|
Continuation of statin therapy in patients with presumed infection: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Atorvastatin; C-Reactive Protein; Cholesterol; Disease Progression; Double-Blind Method; Drug Administration Schedule; Female; Heptanoic Acids; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-6; Male; Middle Aged; Prospective Studies; Pyrroles; Sepsis; Severity of Illness Index; Treatment Outcome | 2011 |
Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial).
Topics: Anti-Inflammatory Agents; Atorvastatin; Disease Progression; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Male; Middle Aged; Patient Readmission; Pyrroles; Sepsis; Severity of Illness Index; Treatment Outcome | 2012 |
A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.
Topics: Aged; Atorvastatin; C-Reactive Protein; Critical Illness; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive Care Units; Interleukin-6; Length of Stay; Lipids; Male; Middle Aged; Prospective Studies; Pyrroles; Sepsis | 2013 |
15 other study(ies) available for atorvastatin and Blood Poisoning
| Article | Year |
|---|---|
Atorvastatin Relieves Cognitive Disorder After Sepsis Through Reverting Inflammatory Cytokines, Oxidative Stress, and Neuronal Apoptosis in Hippocampus.
Topics: Animals; Anxiety; Apoptosis; Astrocytes; Atorvastatin; Behavior, Animal; Cecum; Cognition Disorders; Cytokines; Glial Fibrillary Acidic Protein; Hippocampus; Inflammation Mediators; Learning; Ligation; Male; Memory Disorders; Mice, Inbred ICR; Morris Water Maze Test; Motor Activity; Neurons; Oxidative Stress; Punctures; Sepsis; Survival Analysis | 2020 |
A Population-Based Cohort Study on the Drug-Specific Effect of Statins on Sepsis Outcome.
Topics: Aged; Anti-Infective Agents; Atorvastatin; Cohort Studies; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Respiratory Insufficiency; Rosuvastatin Calcium; Sepsis; Simvastatin; Taiwan; Treatment Outcome | 2018 |
[Protective effects of combined use of atorvastatin and low molecular weight heparin on the inflammatory reaction and pulmonary functions in rats with sepsis].
Topics: Animals; Atorvastatin; Cytokines; Disease Models, Animal; Heparin, Low-Molecular-Weight; HMGB1 Protein; Inflammation; Interleukin-1beta; Interleukin-6; Lung; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha | 2016 |
Statins and sepsis: potential benefit but more unanswered questions.
Topics: Atorvastatin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Male; Pyrroles; Sepsis | 2013 |
Atorvastatin prevents sepsis-induced downregulation of myocardial β1-adrenoceptors and decreased cAMP response in mice.
Topics: Animals; Atorvastatin; Blotting, Western; Catecholamines; Cyclic AMP; Heptanoic Acids; Lactic Acid; Male; Mice; Myocardium; Pyrroles; Real-Time Polymerase Chain Reaction; Receptors, Adrenergic, beta; Sepsis; Ventricular Function, Left | 2014 |
Pleiotropic effects of atorvastatin in experimental sepsis: preservation of β1-adrenoreceptor signaling in the heart.
Topics: Animals; Atorvastatin; Cyclic AMP; Heptanoic Acids; Male; Myocardium; Pyrroles; Receptors, Adrenergic, beta; Sepsis | 2014 |
Combined treatment with atorvastatin and imipenem improves survival and vascular functions in mouse model of sepsis.
Topics: Animals; Anti-Bacterial Agents; Atorvastatin; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imipenem; Male; Mice; Organ Culture Techniques; Sepsis; Survival Rate | 2015 |
Atorvastatin along with imipenem attenuates acute lung injury in sepsis through decrease in inflammatory mediators and bacterial load.
Topics: Acute Lung Injury; Animals; Atorvastatin; Bacterial Load; Drug Therapy, Combination; Imipenem; Inflammation Mediators; Male; Mice; Sepsis | 2015 |
Resolvin Infectious Inflammation by Targeting the Host Response.
Topics: Animals; Atorvastatin; Cells, Cultured; Disease Models, Animal; Docosahexaenoic Acids; Endothelial Cells; Escherichia coli Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Mice; Neutrophils; Phagocytosis; Sepsis | 2015 |
A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis.
Topics: Aged; Anticholesteremic Agents; APACHE; Atorvastatin; Chromatography, High Pressure Liquid; Critical Care; Female; Heptanoic Acids; Humans; Male; Prospective Studies; Pyrroles; Sepsis | 2009 |
Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
Topics: Acetylcholine; Animals; Aorta; Atorvastatin; Biological Factors; Blood Cell Count; Blood Pressure; Calcium Channel Blockers; Cytochrome P-450 Enzyme Inhibitors; Disease Models, Animal; Endothelium, Vascular; Gene Expression; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypotension; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Nitroprusside; Phenylephrine; Pulmonary Artery; Pyrroles; Rats; Rats, Wistar; Sepsis; Vasodilation | 2009 |
Recent trials in critical care nephrology.
Topics: Acute Kidney Injury; Atorvastatin; Critical Care; Critical Illness; Decision Support Systems, Clinical; Evidence-Based Medicine; Female; Hemofiltration; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Male; Metabolic Clearance Rate; Middle Aged; Multicenter Studies as Topic; Pyrroles; Random Allocation; Randomized Controlled Trials as Topic; Renal Circulation; Renal Dialysis; Renal Replacement Therapy; Sepsis; Severity of Illness Index; Survival Rate | 2010 |
Atorvastatin improves survival in septic rats: effect on tissue inflammatory pathway and on insulin signaling.
Topics: Adipose Tissue; Animals; Atorvastatin; Glucose; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Insulin; Interleukin-6; Liver; Male; Muscles; Pyrroles; Rats; Rats, Wistar; Sepsis; Signal Transduction; Tumor Necrosis Factor-alpha | 2010 |
Atorvastatin prevents vascular hyporeactivity to norepinephrine in sepsis: role of nitric oxide and α₁-adrenoceptor mRNA expression.
Topics: Animals; Atorvastatin; Enzyme Inhibitors; Guanylate Cyclase; Heptanoic Acids; Mice; Nitric Oxide; Norepinephrine; Oxadiazoles; Polymerase Chain Reaction; Pyrroles; Quinoxalines; Receptors, Adrenergic, alpha-1; RNA, Messenger; Sepsis; Vasoconstrictor Agents | 2011 |
Re: Statins and sepsis.
Topics: Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Sepsis | 2008 |